218 related articles for article (PubMed ID: 34894176)
1. Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
van der Velden VHJ; Preijers F; Johansson U; Westers TM; Dunlop A; Porwit A; Béné MC; Valent P; Te Marvelde J; Wagner-Ballon O; Oelschlaegel U; Saft L; Kordasti S; Ireland R; Cremers E; Alhan C; Duetz C; Hobo W; Chapuis N; Fontenay M; Bettelheim P; Eidenshink-Brodersen L; Font P; Loken MR; Matarraz S; Ogata K; Orfao A; Psarra K; Subirá D; Wells DA; Della Porta MG; Burbury K; Bellos F; Weiß E; Kern W; van de Loosdrecht A
Cytometry B Clin Cytom; 2023 Jan; 104(1):15-26. PubMed ID: 34894176
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
van de Loosdrecht AA; Kern W; Porwit A; Valent P; Kordasti S; Cremers E; Alhan C; Duetz C; Dunlop A; Hobo W; Preijers F; Wagner-Ballon O; Chapuis N; Fontenay M; Bettelheim P; Eidenschink-Brodersen L; Font P; Johansson U; Loken MR; Te Marvelde JG; Matarraz S; Ogata K; Oelschlaegel U; Orfao A; Psarra K; Subirá D; Wells DA; Béné MC; Della Porta MG; Burbury K; Bellos F; van der Velden VHJ; Westers TM; Saft L; Ireland R
Cytometry B Clin Cytom; 2023 Jan; 104(1):77-86. PubMed ID: 34897979
[TBL] [Abstract][Full Text] [Related]
3. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
[TBL] [Abstract][Full Text] [Related]
4. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.
Porwit A; van de Loosdrecht AA; Bettelheim P; Brodersen LE; Burbury K; Cremers E; Della Porta MG; Ireland R; Johansson U; Matarraz S; Ogata K; Orfao A; Preijers F; Psarra K; Subirá D; Valent P; van der Velden VH; Wells D; Westers TM; Kern W; Béné MC
Leukemia; 2014 Sep; 28(9):1793-8. PubMed ID: 24919805
[TBL] [Abstract][Full Text] [Related]
5. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
van de Loosdrecht AA; Alhan C; Béné MC; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Homburg CH; Ireland R; Jansen JH; Kern W; Malcovati L; Te Marvelde JG; Mufti GJ; Ogata K; Orfao A; Ossenkoppele GJ; Porwit A; Preijers FW; Richards SJ; Schuurhuis GJ; Subirá D; Valent P; van der Velden VH; Vyas P; Westra AH; de Witte TM; Wells DA; Loken MR; Westers TM
Haematologica; 2009 Aug; 94(8):1124-34. PubMed ID: 19546437
[TBL] [Abstract][Full Text] [Related]
6. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.
Westers TM; Ireland R; Kern W; Alhan C; Balleisen JS; Bettelheim P; Burbury K; Cullen M; Cutler JA; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Ogata K; Orfao A; Porwit A; Psarra K; Richards SJ; Subirá D; Tindell V; Vallespi T; Valent P; van der Velden VH; de Witte TM; Wells DA; Zettl F; Béné MC; van de Loosdrecht AA
Leukemia; 2012 Jul; 26(7):1730-41. PubMed ID: 22307178
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic flow cytometry for low-grade myelodysplastic syndromes.
Ogata K
Hematol Oncol; 2008 Dec; 26(4):193-8. PubMed ID: 18412289
[TBL] [Abstract][Full Text] [Related]
8. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
[TBL] [Abstract][Full Text] [Related]
11. Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Kern W; Westers TM; Bellos F; Bene MC; Bettelheim P; Brodersen LE; Burbury K; Chu SC; Cullen M; Porta MD; Dunlop AS; Johansson U; Matarraz S; Oelschlaegel U; Ogata K; Porwit A; Preijers F; Psarra K; Saft L; Subirá D; Weiß E; van der Velden VHJ; van de Loosdrecht A
Cytometry B Clin Cytom; 2023 Jan; 104(1):51-65. PubMed ID: 36416672
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.
van de Loosdrecht AA; Ireland R; Kern W; Della Porta MG; Alhan C; Balleisen JS; Bettelheim P; Bowen DT; Burbury K; Eidenschink L; Cazzola M; Chu SS; Cullen M; Cutler JA; Dräger AM; Feuillard J; Fenaux P; Font P; Germing U; Haase D; Hellström-Lindberg E; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Nikolova V; Ogata K; Oelschlaegel U; Orfao A; Ossenkoppele GJ; Porwit A; Platzbecker U; Preijers F; Psarra K; Richards SJ; Subirá D; Seymour JF; Tindell V; Vallespi T; Valent P; van der Velden VH; Wells DA; de Witte TM; Zettl F; Béné MC; Westers TM
Leuk Lymphoma; 2013 Mar; 54(3):472-5. PubMed ID: 22916713
[TBL] [Abstract][Full Text] [Related]
13. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
[TBL] [Abstract][Full Text] [Related]
15. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: flow cytometry in myelodysplastic syndromes.
van de Loosdrecht AA; Westers TM
J Natl Compr Canc Netw; 2013 Jul; 11(7):892-902. PubMed ID: 23847222
[TBL] [Abstract][Full Text] [Related]
17. Role of flow cytometry in diagnostics of myelodysplastic syndromes--beyond the WHO 2008 classification.
Porwit A
Semin Diagn Pathol; 2011 Nov; 28(4):273-82. PubMed ID: 22195405
[TBL] [Abstract][Full Text] [Related]
18. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
Zhang Y; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
[TBL] [Abstract][Full Text] [Related]
19. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
[TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?
Porwit A
Curr Hematol Malig Rep; 2015 Sep; 10(3):309-17. PubMed ID: 26122389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
